期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

血浆溶血磷脂酸的检测及临床意义 被引量：3

下载PDF
导出
摘要 目的　探讨溶血磷脂酸 (LPA)的检测对预防缺血性 (心 )脑卒中发生的预警作用。方法　分别检测对照组 (3 0～ 50岁 )和实验组 (65岁以上老年人 )血浆LPA的浓度 ,并对结果进行临床分析。结果　共检测 60 2例 65～ 84岁的老年人血浆LPA〔(2 .3 4± 1.2 6) μmol/L〕 ,与对照组〔LPA值为 (1.0 7± 0 .80 ) μmol/L〕相比有显著性差异(P <0 .0 1)。实验组中有 14 5例血浆LPA浓度高于参考值上限 ,平均为 (3 .62± 0 .61) μmol/L。 结论　血浆溶血磷脂酸对缺血性 (心 )
作者 牛国平 马云
机构地区 徐州市医学科学研究所
出处 《徐州医学院学报》 CAS 2003年第6期530-531,共2页 Acta Academiae Medicinae Xuzhou
关键词 血浆 溶血磷脂酸 检测 缺血性(心)脑卒中 预警
分类号 R446.11 [医药卫生—诊断学]
  • 相关文献

参考文献5

  • 1孙玉衡,伍期专,姚存姗,黄世昌,唐朝枢,李振光,包鹤丘,李松,周伟仅.缺血性脑卒中患者血浆溶血磷脂酸水平的初步研究[J].中华医学杂志,2002,82(4):229-231. 被引量：106
  • 2黄世昌,伍期专.溶血磷脂酸与缺血性(心)脑卒中[J].基础医学与临床,2003,23(1):1-4. 被引量：23
  • 3Moolenaar WH. Lysophosphatidic acid, a multifunctional phospholipid messenger [J]. J Biol Chem, 1995,270(22) : 12949 - 12952.
  • 4Eichholtz T, Jalink K, Fahrenfort I, et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets [J].Biochem J , 1993,291 (3) :677 - 680.
  • 5Gerrard JM, Robinson P, Narvey M, et al. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrmnbin is associated with inhibition of platelet aggregation[J]. Bioehem Cell Biol,1993,71 (9 - 10) :432 - 439.

二级参考文献13

  • 1Moolenaar WH. Lysophosphatidic acid,a multifunctional phospholipid messenger. J Biol Chem,1995, 270: 12949-12952.
  • 2Tokumura A, Iimori M, Nishioka Y, et al. Lysophosphatidic acids induce proliferation of cultured vascular smooth muscle cells from rat aorta. Am J Physiol,1994, 267: C204-210.
  • 3Jalink K, Hordijk PL, Growth factor-like effects of lysophosphatidic acid, a novel lipid mediator. Biochim Biophys Acta,1994, 1198: 185-196.
  • 4Xu Y, Shen Z, Wiper DW, et al. Lysophosphatidic acid as a potential biomarker for ovarian and other gynecologic cancers JAMA, 1998,280: 719-723.
  • 5Eichholtz T,Jalink K,Fahrenfort I,et al. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem J,1993, 291 : 677-680.
  • 6Torti M, Tolnai Festetics E, Bertoni A, et al. Activation of human platelets by lysophosphatidic acid. Blood Coagul Fibrinolysis,1996,7: 253-255.
  • 7Zhang J, Rittenhouse SE. Lysophosphatidic acid activates phosphoinositide 3-kinase and phospholipase C in human platelets: inhibitory effects of wortmannin on phosphoinositide 3-kinase and aggregation. Biochem Biophys Res Commun,1995, 211: 484-490.
  • 8Gueguen G, Gaige B, Grevy JM,et al. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry,1999,38: 8440-8450.
  • 9Gerrard JM, Robinson P.Identification of the molecular species of lysophosphatidic acid produced when platelets are stimulated by thrombin. Biochim Biophys Acta, 1989, 1001: 282-285
  • 10Gerrard JM,Robinson P,Narvey M,et al. Increased phosphatidic acid and decreased lysophosphatidic acid in response to thrombin is associated with inhibition of platelet aggregation,Biochem Cell Biol,1993, 71: 432-439.

共引文献116

同被引文献19

  • 1苏成林.血浆溶血磷脂酸在进展性脑梗死诊断中的应用研究[J].神经疾病与精神卫生,2006,6(2):110-112. 被引量：16
  • 2潘颖,苏作军.溶血磷脂酸研究进展[J].现代检验医学杂志,2006,21(4):16-18. 被引量：12
  • 3Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association Pediatrics, 2004,114 : 1708-1733.
  • 4Moolenaar WH. Lysophosphatidie acid, a multifunctional phospholipids messenger. J Biol Chem, 1995, 270 (22): 12949 - 12952.
  • 5Ayusawa M, Sonobe T , Uemura S , et al. Revision of diagnostic guiddines for Kawasaki disease. Pediatric Int, 2005,47 (2):232-235.
  • 6孙景辉,翟淑波.川崎病发病机制研究进展[J].实用儿科临床杂志,2007,22(13):1037-1040. 被引量：27
  • 7中华神经科学会.脑血管疾病分类(1995)各类脑血管疾病诊断要点,中华神经外科学会,脑卒中患者临床神经功能缺损程度评分标准(1995).中华神经科杂志,1996,:29-383,376.
  • 8胡亚美 江裁芳.实用儿科学：7版[M].北京:人民卫生出版社,2002.1191-1203.
  • 9Chau PH,Woo J,Goggins WB,et al.Trends in stroke incidence in Hong Kong differ by stroke subtype[J].Cerebrovasc Dis,2011,31:138-146.
  • 10Katakami N,Takahara M,Kaneto H,et al.Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes[J].Diabetes Care,2010,33(2):390-395.

引证文献3

二级引证文献6

徐州医学院学报
2003年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部